Importance of neurological assessment before bone marrow transplantation for osteopetrosis

Area of Science:

• Pediatric Hematology
• Pediatric Neurology
• Medical Genetics

Background:

• Malignant infantile osteopetrosis (MIO) presents with significant neurological complications.
• Bone marrow transplantation (BMT) is a potential treatment for MIO, effectively addressing osseous and hematological abnormalities.
• A subset of MIO patients exhibits primary retinal and/or generalized neurodegeneration.

Purpose of the Study:

• To highlight the critical distinction between treatable and untreatable manifestations of MIO.
• To emphasize the importance of identifying MIO infants with neurodegenerative components before considering BMT.
• To inform clinical decision-making regarding BMT for MIO.

Main Methods:

• Review of clinical data and outcomes for infants diagnosed with malignant infantile osteopetrosis.
• Analysis of the impact of early bone marrow transplantation on osseous, hematological, and neurological parameters.
• Comparative assessment of neurodegenerative progression in MIO patients with and without primary retinal degeneration.

Main Results:

• Bone marrow transplantation successfully corrects the bone and blood abnormalities in MIO.
• BMT does not halt or reverse the progressive neurodegenerative disorder in affected infants.
• Infants with associated primary retinal degeneration and/or generalized neurodegeneration represent a subgroup with a poor prognosis despite BMT.

Conclusions:

• Early identification of MIO infants with neurodegenerative disorders is crucial for prognosis.
• Bone marrow transplantation is not curative for the neurological aspects of MIO in this specific subgroup.
• Prognostic stratification is essential for guiding treatment decisions and managing expectations in MIO.